Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors

Jan M. Leerink, Elizabeth A. M. Feijen

Research output: Contribution to journal › Comment/Letter to the editor › Academic

1 Citation (Scopus)

Access to Document

@article{05bd3ccde3804245989e672651fa4c8a,

title = "Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors",

author = "Leerink, {Jan M.} and Feijen, {Elizabeth A. M.}",

year = "2024",

month = feb,

doi = "https://doi.org/10.1016/S1470-2045(24)00001-9",

language = "English",

volume = "25",

pages = "154--156",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "2",

}

TY - JOUR

T1 - Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors

AU - Leerink, Jan M.

AU - Feijen, Elizabeth A. M.

PY - 2024/2

Y1 - 2024/2

UR - http://www.scopus.com/inward/record.url?scp=85181956448&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S1470-2045(24)00001-9

DO - https://doi.org/10.1016/S1470-2045(24)00001-9

M3 - Comment/Letter to the editor

C2 - 38215763

SN - 1470-2045

VL - 25

SP - 154

EP - 156

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -